Inside the Mito Town Hall: Insights That Matter
Inside the Mito Town Hall: Insights That Matter The Mito Town Hall meetings have become an important annual touchpoint for […]
Mito Conference 2026: A Landmark Gathering for Mitochondrial Medicine
The Mitochondrial Disease Conference 2026, hosted by Mitocon on 23–24 January in Pisa, brought together clinicians, researchers, patients, and industry partners for
Setback for LHON Treatment in the US: IMP Supports Urgent Patient Need
Setback for LHON Treatment in the US: IMP Supports Urgent Patient Need International Mito Patients (IMP), the global federation representing patient
Strengthening Europe’s Rare Epilepsy Voice Through the E+ Alliance
Strengthening Europe’s Rare Epilepsy Voice Through the E+ Alliance The E+ Alliance presentation outlines a fast‑growing European network dedicated to
EMA grants positive CHMP opinion for KYGEVVI® for Treatment of TK2d
EMA grants positive CHMP opinion for Kygevvi® for Treatment of TK2d International Mito Patients (IMP) and the global mitochondrial disease community
Funding for the SynLeigh Project to Advance New Therapies for Leigh Syndrome
Funding for the SynLeigh Project to Advance New Therapies for Leigh Syndrome IMP, Mitocon and Cure Mito Welcome ERDERA Funding International
IMP Annual Meeting 30-31 May 2026, France
IMP Annual Meeting 30-31 May 2026, France IMP’s Annual Meeting will take place 30–31 May 2026 at Brit Hotel Acropole,
Patients at the Heart of Research: IMP’s Role in the SIMPATHIC Drug Repurposing Project
Patients at the Heart of Research: IMP’s Role in the SIMPATHIC Drug Repurposing Project The SIMPATHIC project continues to make
Rare Disease Day 28 Feb 2026
Rare Disease Day 28 Feb 2026 Rare Disease Day is a global campaign that highlights the 300 million people worldwide
Amplifying Our Collective Voice: IMP at National and International Events
Amplifying Our Collective Voice: IMP at National and International Events As members of IMP, we are part of a global